💙 Les cancers masculins concernent tous les âges.
🎗️ Cancer du testicule : le plus fréquent chez les hommes de 15 à 35 ans.
🎗️ Cancer de la prostate : le plus fréquent chez l’homme en France.
#SantéMasculine#CancerDuTesticule#CancerDeLaProstate
The 2026 ARRIGE Annual conference will take place on 23-24 November 2026 at Next Biosciences, in Midrand (Johannesburg, South Africa) as a hybrid meeting: in-person and remote attendance will be possible. Topic will be: who gets to edit the future? Info at https://t.co/OU7iZFuTUs
Next (5th) ARRIGE Albrecht Müller webinar scheduled on 12 May 2026 online, on updates on gene drive technology, bioethics, regulation and society. Please go to this web for registration:
https://t.co/mqbBPs5uM1
It is with great sadness that we have learnt the passing of Prof. Julian Kinderlerer.
He served as ARRIGE board member from 2021 to 2024. He was Emeritus Prof. of Intellectual Property Law at the University of Cape Town and Former President of the European Group on Ethics (EGE),
𝙁𝙚𝙚𝙡𝙞𝙣𝙜 𝙝𝙚𝙖𝙡𝙩𝙝𝙮 𝙙𝙤𝙚𝙨𝙣’𝙩 𝙢𝙚𝙖𝙣 𝙨𝙠𝙞𝙥𝙥𝙞𝙣𝙜 𝙨𝙘𝙧𝙚𝙚𝙣𝙞𝙣𝙜.
➡️ Who should get screened for CRC?
All adults aged 50 to 74 (the exact age range varies across Europe depending on the country and the type of test).
#eccam2026#healthyageing
We are starting our 2025 ARRIGE annual meeting focused on “access and affordability of gene therapies: challenges for genome editin” both online and in person in Strasbourg. Keynote speaker is Alta Charo
https://t.co/8XceitqB1d
🗓️SAVE THE DATE – 04 Dec 2025, 9:00 CET
Join the 6th DiCE #CRCScreeningSummit to push early detection & prevention of colorectal cancer across
Let’s make screening effective, accessible & equitable.
More details on the agenda soon.
Register now➡️ https://t.co/54RGqoREBR
We're looking for:
🔬 Medical & Scientific Projects Officer
📣 Communications Officer
Join us to reduce the impact of digestive cancers across🇪🇺. You'll be part of a team of individuals committed to making a real difference!
👉 https://t.co/LYjgktTfZq
#hiring@EURACTIVjobsite
Register for the 2025 @ArrigeOrg annual meeting devoted to discuss accessibility and affordability of the novel #CRISPR based gene therapies. In Strasbourg (France) hybrid format, both in-person and online: 28-29 Oct. Free for ARRIGE members. Register at⬇️
https://t.co/e0RiIRdhin
We’re proud to welcome DiCE's new Board of Directors. Their leadership will strengthen our mission, amplify patient voices, & drive progress in healthcare & research. Thanks to former Chair @LieveWierinck and outgoing members for their dedication.
➡️ https://t.co/Q7uEIFrvI5
Life after #CRC is about more than medical recovery; it's about reclaiming connection, confidence, and community.
In the social well-being chapter of our new guide, we share real-life advice on navigating the human side of healing.
📘https://t.co/Fy0mjrXXtx
#ColorectalCancer
We are looking forward to welcoming you for three days of insightful discussions, workshops & networking opportunities.
Our 🔟th Annual Masterclass & General Assembly begins tomorrow. We look forward to meeting you in person!
#DiCEMasterclass25#10YearsOfImpact#ESMOGI2025
[11èmeCongrèsSFMPP] Allocution de Mr Yannick Neuder, Ministre en charge de la Santé et de l'accès aux Soins : de l’intérêt de la médecine génomique pour la prévention et les thérapies ciblées
🗓️ 8 oct 2025 à 11h20
Inscription au Congrès => https://t.co/Y42TUZUShf
#SFMPP2025
𝐓𝐡𝐞 𝟐𝟎𝟐𝟒 𝐃𝐢𝐂𝐄 𝐀𝐧𝐧𝐮𝐚𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐨𝐮𝐭!
It captures a year of action, spotlighting early-age onset cancers, the inaugural ENTERO Conference, EU research, awareness campaigns, and patient-centred advocacy.
Read it here➡️ https://t.co/UTxXiNvkPS